- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ascendis Pharma AS (A71)
Ascendis Pharma AS stock price live, this page displays NASDAQ ASND stock exchange data. View the ASND premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ascendis Pharma AS real time stock price chart below.
What Is the Ascendis Pharma AS Stock Price Today?
The Ascendis Pharma AS stock price today is 141.00.
What Is the Stock Symbol for Ascendis Pharma AS?
The stock symbol for Ascendis Pharma AS is ""ASND.""
What Stock Exchange Does Ascendis Pharma AS Trade On?
Ascendis Pharma AS is listed and trades on the NASDAQ stock exchange.
Is Ascendis Pharma AS a Good Stock to Buy?
Determining whether Ascendis Pharma AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASND quote. (ISIN: US04351P1012)
What Is the Ascendis Pharma AS Stock Price Today?
The Ascendis Pharma AS stock price today is 141.00.
What Is the Stock Symbol for Ascendis Pharma AS?
The stock symbol for Ascendis Pharma AS is ""ASND.""
What Stock Exchange Does Ascendis Pharma AS Trade On?
Ascendis Pharma AS is listed and trades on the NASDAQ stock exchange.
Is Ascendis Pharma AS a Good Stock to Buy?
Determining whether Ascendis Pharma AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASND quote. (ISIN: US04351P1012)
141.00
-5.00(-3.42%)
Closed·
Fair Value
An estimate of a Ascendis Pharma AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
141.00
141.00
52 wk Range
99.00
155.00
A71 Scorecard
Full Analysis
6 analysts have revised their earnings upwards for the upcoming period
A71 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Ascendis Pharma AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
141.00141.00
52 wk Range
99.00155.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
A71 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ascendis Pharma AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Ascendis Pharma AS Company Profile
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Compare A71 to Peers and Sector
Metrics to compare | A71 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipA71PeersSector | |
|---|---|---|---|---|
P/E Ratio | −24.8x | −2.2x | −0.5x | |
PEG Ratio | −0.71 | 0.04 | 0.00 | |
Price/Book | −44.6x | 1.8x | 2.6x | |
Price / LTM Sales | 22.9x | 8.7x | 3.2x | |
Upside (Analyst Target) | - | 98.7% | 41.2% | |
Fair Value Upside | Unlock | 6.9% | 6.2% | Unlock |
Earnings
Latest Release
May 01, 2025
EPS / Forecast
-1.58 / -1.47
Revenue / Forecast
100.95M / 93.49M
People Also Watch
FAQ
What Stock Exchange Does Ascendis Pharma AS Trade On?
Ascendis Pharma AS is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for Ascendis Pharma AS?
The stock symbol for Ascendis Pharma AS is "A71."
What Is the Ascendis Pharma AS Market Cap?
As of today, Ascendis Pharma AS market cap is 8.61B.
What Is Ascendis Pharma AS's Earnings Per Share (TTM)?
The Ascendis Pharma AS EPS (TTM) is -5.82.
When Is the Next Ascendis Pharma AS Earnings Date?
Ascendis Pharma AS will release its next earnings report on 08 Sept 2025.
From a Technical Analysis Perspective, Is A71 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ascendis Pharma AS Stock Split?
Ascendis Pharma AS has split 0 times.
How Many Employees Does Ascendis Pharma AS Have?
Ascendis Pharma AS has 1017 employees.
What is the current trading status of Ascendis Pharma AS (A71)?
As of 29 Jul 2025, Ascendis Pharma AS (A71) is trading at a price of 141.00, with a previous close of 146.00. The stock has fluctuated within a day range of 141.00 to 141.00, while its 52-week range spans from 99.00 to 155.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.